
Keywords: پفو، واحدهای تشکیل پلاک; HER2, human epidermal growth factor receptor 2; FRG™ KO, [ Fah(-/-) R ag2(-/-)Il2r g (-/-)]); NOD, Non-obese diabetic; Ad:uPA, Adenovirus Urokinase Plasminogen Activator; pfu, plaque forming units; DMEM, Dulbecco's Modified Eagle Medium; HCM, Hepatocyte C